Loading...
| A15377 | Pages: NA | Mar 2022 | 32 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Spina Bifida & Hydrocephalus Market
Request Now !Spina bifida & hydrocephalus are two rare forms of disease, for which, there are unfortunately no cures but preventive measures are available. Spina bifida is a malformation of the spinal cord that generally occurs during the early stages of pregnancy and hydrocephalus is the abnormal accumulation of cerebrospinal in the cavities of the brain. These conditions are birth defects, which usually caused from the failure or closing of the neural tube during the early fetal development and might result in nerve damage, increase in intracranial pressure in the inside of the skull, convulsions, blindness, and mental disability.
Market Scope and Structure Analysis
Report Metric | Details |
Market Size Available for Years | 2021–2030 |
Base Year Considered | 2020 |
Forecast Period | 2021–2030 |
Forecast Unit | Value (USD) |
Segments Covered | Disease Type, Treatment, Distribution Channel, and Region |
Companies Covered | BD, Boston Scientific Corporation, B. Braun Melsungen AG, C.B. Fleet Company, Covidien, Cook, FUJIFILM Corporation, Medline Industries, Inc., KARL STORZ SE & Co. KG, Olympus Corporation, and Medtronic |
COVID-19 Impact Analysis
Pharmaceutical and biotech companies together with governments globally are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges.
Currently, about 115 vaccine samples and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the Spina bifida & hydrocephalus market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish SPINA Bifida & Hydrocephalus Market
In 2020, Alcyone Lifesciences received the approval of the Food and Drug Administration (FDA) to relaunch the ReFlow shunt system to treat hydrocephalus.
In 2021, UC Davis Health started a clinical trial with the approval of the FDA, known as the CuRe Trial, which is a cellular therapy to treat spina bifida.
Key Benefits of Report
Questions Answered in SPINA Bifida & Hydrocephalus Market Report
Key Market Segments
| Segments | Sub-segments |
|---|---|
| Disease Type |
|
| Treatment |
|
| Distribution Channel |
|
| Region |
|
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
